Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2012 (2012), Article ID 234515, 7 pages
http://dx.doi.org/10.1155/2012/234515
Case Report

Is Thymoglobulin or Rituximab the Cause of This Serum Sickness? A Case Report of Serum Sickness Dilemma and Literature Review

Department of Nephrology, The University of New Mexico, Albuquerque, NM 87131, USA

Received 15 May 2012; Accepted 30 August 2012

Academic Editor: David W. Eisele

Copyright © 2012 Amarpreet Sandhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Todd and S. M. Helfgott, “Serum sickness following treatment with rituximab,” Journal of Rheumatology, vol. 34, no. 2, pp. 430–433, 2007. View at Google Scholar · View at Scopus
  2. T. J. Lawley, L. Bielory, and P. Gascon, “A prospective clinical and immunologic analysis of patients with serum sickness,” New England Journal of Medicine, vol. 311, no. 22, pp. 1407–1413, 1984. View at Google Scholar · View at Scopus
  3. S. R. Heckbert, W. S. Stryker, K. L. Coltin, J. E. Manson, and R. Platt, “Serum sickness in children after antibiotic exposure: estimates of occurrence and morbidity in a health maintenance organization population,” American Journal of Epidemiology, vol. 132, no. 2, pp. 336–342, 1990. View at Google Scholar · View at Scopus
  4. B. Tanriover, P. Chuang, B. Fishbach et al., “Polyclonal antibody-induced serum sickness in renal transplant recipients: treatment with therapeutic plasma exchange,” Transplantation, vol. 80, no. 2, pp. 279–281, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Pijpe, G. W. Van Imhoff, F. K. L. Spijkervet et al., “Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study,” Arthritis and Rheumatism, vol. 52, no. 9, pp. 2740–2750, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. H. Snow, A. C. Cannella, R. B. Stevens, and T. R. Mikuls, “Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppression,” Arthritis Care and Research, vol. 61, no. 9, pp. 1271–1274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. P. T. T. Pham, P. M. Pham, J. M. Miller, and P. C. T. Pham, “Polyclonal antibody-induced serum sickness presenting as rapidly progressive descending paralysis,” Transplantation, vol. 83, no. 12, p. 1657, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. S. L. Da Silva, R. M. A. Passos, D. R. Waisberg, and M. V. F. Park, “Serum sickness and severe acute renal failure after rabbit antithymocyte globulin treatment in aplastic anemia: a case report,” Journal of Pediatric Hematology/Oncology, vol. 33, no. 1, pp. 43–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Boothpur, K. L. Hardinger, R. M. Skelton et al., “Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposure,” American Journal of Kidney Diseases, vol. 55, no. 1, pp. 141–143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. B. Andresdottir, K. J. Assmann, and J. F. Wetzels, “Glomerulonephritis caused by acute serum sickness,” Nederlands Tijdschrift voor Geneeskunde, vol. 141, pp. 1417–1420, 1997. View at Google Scholar
  11. A. L. Lundquist, R. S. Chari, J. H. Wood et al., “Serum sickness following rabbit antithymocyte-globulin induction in a liver transplant recipient: case report and literature review,” Liver Transplantation, vol. 13, no. 5, pp. 647–650, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Disperati, L. K. Hicks, and R. Buckstein, “Rituximab-induced serum sickness in a patient with follicular lymphoma,” Leukemia and Lymphoma, vol. 48, no. 8, pp. 1633–1635, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. N. A. DeMonaco and S. A. Jacobs, “Serum sickness in a patient with follicular lymphoma after rituximab and radioimmunotherapy with ibritumomab tiuxetan,” Clinical Nuclear Medicine, vol. 32, no. 12, pp. 933–934, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. A. D'Arcy and M. Mannik, “Serum sickness secondary to treatment with the murine—human chimeric antibody IDEC-C2B8 (rituximab),” Arthritis and Rheumatism, vol. 44, no. 7, pp. 1717–1718, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Herishanu, “Rituximab-induced serum sickness,” American Journal of Hematology, vol. 70, no. 4, p. 329, 2002. View at Google Scholar · View at Scopus
  16. B. Hellerstedt and A. Ahmed, “Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment,” Annals of Oncology, vol. 14, no. 12, p. 1792, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. C. P. Pirquet von Cesanatico and B. Schick, Serum Sickness, Williams & Wilkins, Baltimore, Md, USA, 1951.
  18. C. Prin Mathieu, E. Renoult, A. Kennel De March, M. C. Béné, M. Kessler, and G. C. Faure, “Serum anti-rabbit and anti-horse IgG, IgA, and IgM in kidney transplant recipients,” Nephrology Dialysis Transplantation, vol. 12, no. 10, pp. 2133–2139, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Nangaku and W. G. Couser, “Mechanisms of immune-deposit formation and the mediation of immune renal injury,” Clinical and Experimental Nephrology, vol. 9, no. 3, pp. 183–191, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. H. L. Christiaans and J. P. Van Hooff, “Plasmapheresis and RATG-induced serum sickness,” Transplantation, vol. 81, no. 2, p. 296, 2006. View at Publisher · View at Google Scholar · View at Scopus